Login / Signup

In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.

Aliaa FouadYasmeen AbouelhassanChristian M Gill
Published in: The Journal of antimicrobial chemotherapy (2023)
Synergy and no antagonism was observed with a combination of sulbactam-durlobactam and cefepime; further in vivo pharmacokinetic/pharmacodynamics data and clinical correlation are necessary to support our findings.
Keyphrases
  • acinetobacter baumannii
  • electronic health record
  • big data
  • multidrug resistant
  • pseudomonas aeruginosa